MEDADVISOR'S new agreement with US-based device manufacturer iHealth (PD breaking news yesterday) promises to "deliver a new revenue stream for MedAdvisor Network Pharmacies".
iHealth is a subsidiary of Chinese firm Andon Health, one of the country's largest OEM health technology producers with operations in Paris, Hong Kong and Singapore as well as California.
iHealth devices include blood pressure monitors, pulse oximeters, blood glucose monitors and activity and sleep trackers, with the data collected set to be accessible via the MedAdvisor application.
MedAdvisor ceo Robert Read said the move would expand his company's offering to incorporate new services for testing and managing key health metrics such as weight, blood pressure and blood glucose levels.
Under the agreement with iHealth's local distributor Propell Pty Ltd, pharmacies will be able to order iHealth devices through the MedAdvisor App, providing an additional revenue stream, while patients will be able to use the integration to better monitor and manage their health.
iHealth spokesman Wade Shu said the partnership with MedAdvisor would help the company access "an extensive network of pharmacies and over 750,000 patients who would derive significant benefits from our solutions".
The above article was sent to subscribers in Pharmacy Daily's issue from 30 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 May 17
